On the public citation graph

Tumor Necrosis Factor-Alpha Inhibitors-Induced Systemic Lupus Erythematosus: A Real-World Pharmacovigilance Study Based on the Faers Database

0 signed · 37 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ijc.34848openalex-extracted
Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database
inferredcites →https://doi.org/10.1007/bf02786470openalex-extracted
The paradigm of Th1 and Th2 cytokines
inferredcites →https://doi.org/10.1007/s10067-007-0728-5openalex-extracted
Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFα blocking agents in rheumatoid arthritis
inferredcites →https://doi.org/10.1007/s40264-014-0146-yopenalex-extracted
Performance of Probabilistic Method to Detect Duplicate Individual Case Safety Reports
inferredcites →https://doi.org/10.1007/s40264-022-01210-2openalex-extracted
Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance Analysis
inferredcites →https://doi.org/10.1016/j.autrev.2014.05.005openalex-extracted
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort
inferredcites →https://doi.org/10.1016/j.autrev.2023.103332openalex-extracted
Tumor necrosis factor-α inhibitor-related autoimmune disorders
inferredcites →https://doi.org/10.1016/j.cjca.2013.11.011openalex-extracted
Drug-Induced Lupus Erythematosus Presenting With Cardiac Tamponade: A Case Report and Literature Review
inferredcites →https://doi.org/10.1016/j.imlet.2005.08.001openalex-extracted
Proinflammatory cytokine (IL-1β, IL-6, IL-12, IL-18 and TNF-α) levels in sera of patients with subacute cutaneous lupus erythematosus (SCLE)
inferredcites →https://doi.org/10.1016/j.intimp.2020.107049openalex-extracted
Tumor necrosis factor inhibitor-induced pleuropericarditis: A retrospective evaluation using data from VigiBase
inferredcites →https://doi.org/10.1023/a:1009692902805openalex-extracted
Role of apoptosis in autoimmunity
inferredcites →https://doi.org/10.1038/9544openalex-extracted
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
inferredcites →https://doi.org/10.1038/sj.clpt.6100258openalex-extracted
Novel Statistical Tools for Monitoring the Safety of Marketed Drugs
inferredcites →https://doi.org/10.1080/14740338.2017.1372421openalex-extracted
Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)
inferredcites →https://doi.org/10.1080/14740338.2020.1799975openalex-extracted
A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib
inferredcites →https://doi.org/10.1093/ndt/gfh832openalex-extracted
Development of glomerulonephritis during anti-TNF-α therapy for rheumatoid arthritis
inferredcites →https://doi.org/10.1093/rheumatology/kep080openalex-extracted
Anti-TNF-induced lupus
inferredcites →https://doi.org/10.1097/00054725-199911000-00009openalex-extracted
Th1/Th2 Cells
inferredcites →https://doi.org/10.1097/bor.0b013e32835b1366openalex-extracted
Biologics-induced autoimmune diseases
inferredcites →https://doi.org/10.1097/md.0b013e3181441a68openalex-extracted
Autoimmune Diseases Induced by TNF-Targeted Therapies
inferredcites →https://doi.org/10.1111/apt.15097openalex-extracted
Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel disease
inferredcites →https://doi.org/10.1136/annrheumdis-2018-214598openalex-extracted
Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database
inferredcites →https://doi.org/10.1136/ard.2004.024182openalex-extracted
Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα
inferredcites →https://doi.org/10.1136/ard.61.11.1031openalex-extracted
New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis
inferredcites →https://doi.org/10.1136/rmdopen-2016-000314openalex-extracted
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
inferredcites →https://doi.org/10.1177/0961203308100560openalex-extracted
Etanercept-associated SLE with lupus nephritis
inferredcites →https://doi.org/10.1182/blood-2011-04-325225openalex-extracted
Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
inferredcites →https://doi.org/10.1186/ar1715openalex-extracted
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
inferredcites →https://doi.org/10.1186/s40425-019-0754-2openalex-extracted
Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system
inferredcites →https://doi.org/10.1517/14740338.2014.915938openalex-extracted
A comparison of disproportionality analysis methods in national adverse drug reaction databases of China
inferredcites →https://doi.org/10.1586/1744666x.4.2.275openalex-extracted
Autoantibody production in patients treated with anti-TNF-α
inferredcites →https://doi.org/10.2174/1573397115666190506152729openalex-extracted
Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept
inferredcites →https://doi.org/10.24875/pjdv.23000061openalex-extracted
Drug-induced lupus erythematosus
inferredcites →https://doi.org/10.3346/jkms.2006.21.5.946openalex-extracted
Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis
inferredcites →https://doi.org/10.3892/ijmm.2022.5098openalex-extracted
Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review)
inferredcites →https://doi.org/10.4049/jimmunol.159.2.919openalex-extracted
CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages
inferredcites →https://doi.org/10.7150/ijms.6048openalex-extracted
Data Mining of the Public Version of the FDA Adverse Event Reporting System
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.